BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 18160603)

  • 1. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
    Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
    Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
    Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
    Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
    Kher A; Bauersachs R; Nielsen JD
    Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of adverse perinatal outcome in inherited thrombophilias: a clinical study.
    Kosar A; Kasapoglu B; Kalyoncu S; Turan H; Balcik OS; Gümüs EI
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):14-8. PubMed ID: 21042205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis and treatment of thrombophilia in pregnancy.
    Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
    Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
    James AH; Brancazio LR; Ortel TL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilia and antithrombotic therapy in women with recurrent spontaneous abortions.
    Deligiannidis A; Parapanissiou E; Mavridis P; Tabakoudis G; Mavroudi A; Papastavrou T; Tabakoudis P
    J Reprod Med; 2007 Jun; 52(6):499-502. PubMed ID: 17694967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the role of low-molecular-weight heparins in pregnancy.
    Greer IA
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies.
    Deruelle P; Denervaud M; Hachulla E; Ducloy-Bouthors AS; Valat AS; Puech F; Trillot N; Hatron PY; Subtil D
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):73-8. PubMed ID: 16242833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia and the obstetric patient.
    Cleary-Goldman J; Bettes B; Robinson JN; Norwitz E; Schulkin J
    Obstet Gynecol; 2007 Sep; 110(3):669-74. PubMed ID: 17766616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilia, thrombosis and pregnancy.
    Eldor A
    Thromb Haemost; 2001 Jul; 86(1):104-11. PubMed ID: 11486995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of systemic hemostatic parameters by enoxaparin during gestation in women with thrombophilia and pregnancy loss.
    Sarig G; Blumenfeld Z; Leiba R; Lanir N; Brenner B
    Thromb Haemost; 2005 Nov; 94(5):980-5. PubMed ID: 16363240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD; Pineo GF
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombophilia, anticoagulant therapy and pregnancy].
    Boda Z; László P; Pfliegler G; Tornai I; Rejtö L; Schlammadinger A
    Orv Hetil; 1998 Dec; 139(52):3113-6. PubMed ID: 9914731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and management of venous thromboembolism in pregnancy.
    James AH
    Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women.
    Folkeringa N; Brouwer JL; Korteweg FJ; Veeger NJ; Erwich JJ; Holm JP; van der Meer J
    Br J Haematol; 2007 Feb; 136(4):656-61. PubMed ID: 17223916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.